KENNETH BATE Insider Trading $GNCA GENOCEA BIOSCIENCES, INC.
Get free email notifications about insider trading for KENNETH BATE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH BATE. KENNETH BATE is EVP; Chief Financial Officer in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and ExecVP; Head of Commercial Ops in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Epizyme, Inc. ($EPZM).
KENNETH BATE in GENOCEA BIOSCIENCES, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KENNETH BATE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 19 2020
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KENNETH BATE in GENOCEA BIOSCIENCES, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, BMRN, CATB, EPZM, GNCA, SNTA, MLNM, VNDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 19 2020 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 2.22 | 15,000 | 33,300 | 15,000 | |
| Jul 19 2019 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 3.66 | 5,625 | 20,588 | 5,625 | |
| Jun 25 2018 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 0.99 | 45,000 | 44,550 | 45,000 | |
| Jun 15 2017 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 5.34 | 15,000 | 80,100 | 15,000 | |
| Jun 09 2016 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 4.64 | 15,000 | 69,600 | 15,000 | |
| Mar 02 2015 | GNCA | GENOCEA BIOSCIENCE ... | BATE KENNETH | Director | Option Exercise | A | 9.08 | 5,042 | 45,781 | 5,042 |
Page: 1